PPA
YMAB

Parametric Portfolio Associates’s Y-mAbs Therapeutics YMAB Stock Holding History

Parametric Portfolio Associates’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$253K Buy
21,265
+6,131
+41% +$63K ﹤0.01% 3346
2021
Q4 		$245K Buy
15,134
+4,083
+37% +$87.3K ﹤0.01% 3351
2021
Q3 		$315K Sell
11,051
-36,423
-77% -$1.15M ﹤0.01% 3283
2021
Q2 		$1.6M Buy
47,474
+30,604
+181% +$982K ﹤0.01% 2550
2021
Q1 		$510K Sell
16,870
-2,726
-14% -$112K ﹤0.01% 3492
2020
Q4 		$970K Sell
19,596
-132
-0.7% -$6.11K ﹤0.01% 3071
2020
Q3 		$757K Buy
19,728
+1,017
+5% +$40.5K ﹤0.01% 3076
2020
Q2 		$808K Buy
+18,711
New +$708K ﹤0.01% 3033

Other funds holding YMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return